SS Innovations International (SSII) Current Deferred Revenue (2022 - 2026)
SS Innovations International (SSII) reported Current Deferred Revenue of $3.6 million for Q1 2026, up 91.45% on a YoY basis from $1.9 million in Q1 2025, and down 65.57% sequentially from $10.4 million in Q4 2025.
SS Innovations International (SSII) Current Deferred Revenue (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Current Deferred Revenue data on file, last reported at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue rose 91.45% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 91.45% YoY), and the FY2025 full-year result was $10.4 million, up 61.28% from the prior year.
- Current Deferred Revenue retreated to $3.6 million in Q1 2026, from $10.4 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $10.4 million in Q4 2025 to a low of $37630.0 in Q2 2023.
- A 5-year average of $2.8 million and a median of $1.1 million in 2023 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue jumped 2394.43% in 2023 and gained 23.23% in 2024, its largest moves.
- Tracing SSII's Current Deferred Revenue over 5 years: stood at $43917.0 in 2022, then jumped by 2394.43% to $1.1 million in 2023, then soared by 489.02% to $6.5 million in 2024, then surged by 61.28% to $10.4 million in 2025, then sank by 65.57% to $3.6 million in 2026.
- Business Quant data shows SSII's Current Deferred Revenue at $3.6 million in Q1 2026, $10.4 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Mn |
| Dec 31, 2025 | 10.41 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 8.19 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 6.45 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 395,565.00 |
| Mar 31, 2024 | 252,265.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 888,964.00 |
| Jun 30, 2023 | 37,630.00 |
| Dec 31, 2022 | 43,917.00 |